ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis

Pancreatic cancer is one of the most lethal cancers and its prognosis is extremely poor. Clarification of molecular mechanisms and identification of prognostic biomarkers are urgently needed. Though we previously found that LGMN was involved in pancreatic carcinoma progression, the upstream regulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Qiang, Ni, Chenming, Lin, Yingying, Sun, Xu, Shen, Zhenhua, Zhang, Minjie, Han, Shuwen, Shi, Jiemin, Mao, Jing, Yang, Zhe, Wang, Weilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711721/
https://www.ncbi.nlm.nih.gov/pubmed/34966781
http://dx.doi.org/10.3389/fmolb.2021.764900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711721/
https://www.ncbi.nlm.nih.gov/pubmed/34966781
http://dx.doi.org/10.3389/fmolb.2021.764900

Ejemplares similares